Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: The PRIME study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 7, 2002, Pages 1155-1161

  Luc, Gérald ^a   Bard, Jean Marie ^a   Ferrières, Jean ^b   Evans, Alun ^c   Amouyel, Philippe ^a   Arveiler, Dominique ^d   Fruchart, Jean Charles ^a   Ducimetière, Pierre ^e  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

Apolipoprotein A I; Coronary heart disease; Lipoprotein A I; Prospective study

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LIPOPROTEIN A1; LIPOPROTEIN A2; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

ANGINA PECTORIS; APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; FRANCE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORTHERN IRELAND; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036061901     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000022850.59845.E0     Document Type: Article

References (33)

1. Trends in cardiovascular disease mortality in industrialized countries since 1950
2. The burden of cardiovascular diseases mortality in Europe: Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe
3. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project
4. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years: The WHO MONICA Project
5. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: The ECTIM Study
6. Subpopulations of apolipoprotein A-I in human high-density lipoproteins: Their metabolic properties and response to drug therapy
7. David Rubinstein Memorial Lecture: The biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins
8. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease
9. Apolipoprotein A-I containing lipoproteins in coronary artery disease
10. Study of lipoprotein particles LpAI and LpAI:AII in patients before coronary bypass surgery
11. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease
12. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin- dependent diabetes mellitus
13. Methodologic problems and standards in case-control research
14. The PRIME study: Classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland
15. The Tromso Heart Study: Serum apolipoprotein AI concentration in relation to future coronary heart disease
16. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease
17. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction
18. A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women
19. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men
20. Apolipoproteins and ischaemic heart disease: Implications for screening
21. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study
22. Differential electroimmunoassay of human LpA-I lipoprotein particles on readyto-use plates
23. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
24. Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study
25. The Tromso heart-study: High-density lipoprotein and coronary heart-disease: A prospective case-control study
26. High density lipoprotein cholesterol and incidence of coronary heart disease: The Israeli Ischemic Heart Disease Study
27. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women: The Framingham Study
28. Comparison of improved precipitation methods for quantification of high-density lipoptotein cholesterol
29. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: The prospective epidemiological study of myocardial infarction (PRIME study)
30. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies
31. Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma
32. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
33. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B, III: Comparability of apolipoprotein A-I values by use of international reference material